At Mount Sinai Fertility (MSF), we are committed to ensuring a safe, welcoming and inclusive environment for all people regardless of sex, gender, or sexual orientation. While we seek to provide this care to all, 2SLGBTQ+ communities continue to have unique reproductive healthcare needs that we strive to fulfil.
Considerations for 2SLGBTQI+
What to expect when visiting Mount Sinai Fertility
During your initial consultation, you will meet with a physician or nurse practitioner to discuss your health history and family-building goals. If you are proceeding with fertility treatment, you will also be asked to undergo some initial testing which may include bloodwork, ovarian reserve testing for individuals with ovaries (which involves an internal ultrasound), and semen analysis for individuals who produce sperm. Some people may also be recommended to have testing of their fallopian tubes and/or uterus. Once the tests are complete and we have reviewed the results, we will meet again to discuss possible treatment options.
MSF has a wide range of assisted-reproductive technologies to help 2SLGBTQI+ individuals in building their families or preserving their fertility for the future. These options include:
- Donor eggs*
- Donor sperm*
- Gestational carrier options*
- Intrauterine insemination (IUI)/Donor Insemination (DI)
- InVitro Fertilization (IVF)
- Reciprocal IVF
- Fertility preservation for trans/non-binary/gender people who produce sperm
- Fertility preservation for trans/non-binary/gender people with ovaries and uteri
*Due to recent changes in Health Canada regulation, some third party reproduction options are on hold at Mount Sinai Fertility as we update our procedures to comply with these regulations.
Fertility preservation for trans people who produce sperm
Medically Indicated Fertility Preservation may provide the option of having genetically related children now or in the future. Sperm banking can be done prior to the initiation of hormone replacement therapy. If hormone replacement therapy has begun, individuals may need to stop medications for a short time period prior to sperm banking. It is recommended to stop any hormone therapy 3 months prior to scheduling a sperm banking appointment.
Fertility preservation for trans people with ovaries
Medically Indicated Fertility Preservation may provide the option of having genetically related children now or in the future. If hormone replacement therapy has begun, individuals will need to stop medication for approximately 4 weeks before starting an egg freezing cycle, and remain off throughout the cycle (approximately 6 weeks).
Mount Sinai Fertility 2SLGBTQI+ Care Advisory committee
Established in 2016, the MSF LGBT Care Advisory Committee has played an important role in shaping our clinic to be welcoming and inclusive of all individuals who come through our doors. The committee meets quarterly to identify and work to resolve issues and barriers to achieving an equitable experience for LGBT individuals and families at MSF.
Information and Resources
- Fertility awareness for people with ovaries
- Parenting options for LGBTQ+ people
- The 519 (fertility, pregnancy and parenting support classes)
- Rainbow Health Ontario, a program of Sherbourne Health, has recently launched a new website with LGBTQ health resources.
- Birthing and Breast or Chestfeeding Trans People and Allies Facebook Group
- Swelling with Pride: Queer Conception and Adoption Stories (Edited by Sara Graefe)
- Egale Canada 2SLGBTQI Family Planning videos: Click Here